Overview
Sanda Morar is a Hematologist Oncology specialist and an Oncologist in Las Vegas, Nevada. Dr. Morar is rated as an Experienced provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Myeloproliferative Neoplasms (MPN), Paget Disease of the Breast, Breast Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Morar is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- POS
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3131 La Canada St, Las Vegas, NV 89169
Comprehensive Cancer Centers Of Nevada
Telehealth Visits are Available. Dr. Tibayan is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Drug-Induced Thrombocytopenia, and Iron Deficiency Anemia.
Comprehensive Cancer Centers Of Nevada
Telehealth Visits are Available Hamidreza Sanatinia, MD is a medical oncologist at Comprehensive Cancer Centers of Nevada (CCCN). He is board certified in internal medicine and medical oncology. Cancer affects every one of us. I believe in treating the patient as if we are treating our own family members. As a physician, it is our duty to give the best and most current advice to our patients. I encourage academic discussion and the sharing of the latest research among physicians to improve the lives of our patients. We are well trained in treating diseases; but the overall care of the patient as a whole comes first.Cancer affects every one of us. I believe in treating the patient as if we are treating our own family members. As a physician, it is our duty to give the best and most current advice to our patients. I encourage academic discussion and the sharing of the latest research among physicians to improve the lives of our patients. We are well trained in treating diseases; but the overall care of the patient as a whole comes first. Dr. Sanatinia is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Paget Disease of the Breast, Agranulocytosis, Chronic Familial Neutropenia, and Acute Mountain Sickness.
Sunrise Mountainview Multispecialty Clinics LLC
Carolyn Mulroney is a Hematologist Oncology specialist and a Hematologist in Las Vegas, Nevada. Dr. Mulroney is rated as a Distinguished provider by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Multiple Myeloma, Non-Hodgkin Lymphoma, Follicular Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Morar isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Morar isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Mountain SicknessDr. Morar isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Morar isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Morar isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer

